0001415889-23-005592.txt : 20230329
0001415889-23-005592.hdr.sgml : 20230329
20230329205901
ACCESSION NUMBER: 0001415889-23-005592
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230327
FILED AS OF DATE: 20230329
DATE AS OF CHANGE: 20230329
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Imran Talat
CENTRAL INDEX KEY: 0001869579
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40672
FILM NUMBER: 23776917
MAIL ADDRESS:
STREET 1: C/O RANI THERAPEUTICS HOLDINGS, INC.
STREET 2: 2051 RINGWOOD AVENUE
CITY: SAN JOSE
STATE: CA
ZIP: 95131
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Rani Therapeutics Holdings, Inc.
CENTRAL INDEX KEY: 0001856725
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2051 RINGWOOD AVENUE
CITY: SAN JOSE
STATE: CA
ZIP: 95131
BUSINESS PHONE: (408) 457-3700
MAIL ADDRESS:
STREET 1: 2051 RINGWOOD AVENUE
CITY: SAN JOSE
STATE: CA
ZIP: 95131
4
1
form4-03302023_120352.xml
X0407
4
2023-03-27
0001856725
Rani Therapeutics Holdings, Inc.
RANI
0001869579
Imran Talat
C/O RANI THERAPEUTICS LLC
2051 RINGWOOD AVE
SAN JOSE
CA
95131
true
true
false
false
CEO
0
Class A Common Stock
2023-03-27
4
A
0
353500
0
A
444445
D
Stock Option (Right to Buy)
5.44
2023-03-27
4
A
0
575600
0
A
2033-03-26
Class A Common Stock
575600
575600
D
The shares subject to the restricted stock unit grant vest as follows: 1/16th of the RSUs shall vest quarterly over four years from March 27, 2023.
Includes 12,343 shares held by VH Moll, L.P. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.
The shares subject to the option vest as follows: 1/48th of the shares subject to the option vest monthly over four years from March 27, 2023.
/s/ Josh Seidenfeld, Attorney-in-Fact
2023-03-29